US › Healthcare

Satellos Bioscience Inc. Common Stock (MSLE)

US · Healthcare · Biotechnology

$10.03+2.45%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-9.8M
Profit YoY
-59.1%
EPS
$-0.53
EPS estimate
$-0.59

EPS came in at -0.53 against a street estimate of -0.59 — a beat of 10.2%.

Key statistics

Market cap
$208.1M
Forward P/E
0.0
P/B
2.95
Book value
$3.39
EPS (TTM)
$-1.79
52-week high
$13.39
52-week low
$4.85
50-day MA
$7.59
200-day MA
$7.71
Beta
1.17

Analyst view

with an average price target of $27.67.

Shareholding

Insiders
6.48%
Institutions
50.68%

Largest institutional holders

FundStake
Franklin Resources Inc4.51%
Siren, L.L.C.4.28%
Vivo Capital, LLC3.91%
Avidity Partners Management LP3.72%
Point72 Asset Management, L.P.3.32%
Woodline Partners LP2.40%
Sphera Funds Management Ltd.2.35%
Suvretta Capital Management, LLC2.28%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Satellos Bioscience Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.